Skip to main content
. 2022 May 10;22:146. doi: 10.1186/s12905-022-01737-7

Fig. 2.

Fig. 2

Dysmenorrhea and dyspareunia intragroup and intergroup comparison of women with endometriosis-associated pain symptoms at baseline and at 3, 6 and 12 months of 24/4 regimen 17β-estradiol (1.5 mg) and Nomegestrol Acetate (2.5 mg) (E2/NOMAC) combined oral contraceptive, or of Dienogest (DNG) 2 mg daily